Abbreviated Company Accounts - SUPERPHARM BOLTON LTD

Abbreviated Company Accounts - SUPERPHARM BOLTON LTD


Registered Number 09449153

SUPERPHARM BOLTON LTD

Abbreviated Accounts

31 July 2016

SUPERPHARM BOLTON LTD Registered Number 09449153

Abbreviated Balance Sheet as at 31 July 2016

Notes 2016 2015
£ £
Fixed assets
Investments 2 2,359,905 -
2,359,905 -
Current assets
Debtors 12,210 2
Cash at bank and in hand 92 -
12,302 2
Creditors: amounts falling due within one year (608,468) -
Net current assets (liabilities) (596,166) 2
Total assets less current liabilities 1,763,739 2
Creditors: amounts falling due after more than one year (1,162,047) -
Total net assets (liabilities) 601,692 2
Capital and reserves
Called up share capital 3 102 2
Share premium account 583,643 -
Profit and loss account 17,947 -
Shareholders' funds 601,692 2
  • For the year ending 31 July 2016 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 30 March 2017

And signed on their behalf by:
MR M NAHEEM, Director
MR S KHAN, Director

SUPERPHARM BOLTON LTD Registered Number 09449153

Notes to the Abbreviated Accounts for the period ended 31 July 2016

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Other accounting policies
Consolidation
In the opinion of the directors, the company and its subsidiary undertakings comprise a small group. The company has therefore taken advantage of the exemption provided by Section 398 of the Companies Act 2006 not to prepare group accounts.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

2Fixed assets Investments
COST
Additions: £2,359,905
At 31 July 2016: £2,359,905

NET BOOK VALUE
At 31 July 2016: £2,359,905
At 31 July 2015: £NIL

The company owns 100% of the issued share capital of the companies listed below,

Aggregate capital and reserves

Wellbrook Ventures Limited 2016: £614,276, 2015: £NIL
Oakfield Enterprises Limited 2016: £379,618, 2015: £NIL

Profit and (loss) for the year

Wellbrook Ventures Limited 2016: £446,669, 2015: £NIL
Oakfield Enterprises Limited 2015: £175,444, 2015: £NIL

Under the provision of section 398 of the Companies Act 2006 the company is exempt from preparing consolidated accounts and has not done so, therefore the accounts show information about the company as an individual entity.

3Called Up Share Capital
Allotted, called up and fully paid:
2016
£
2015
£
100 Ordinary shares of £1 each (2 shares for 2015) 100 2
1 B Ordinary share of £1 each (0 shares for 2015) 1 0
1 C Ordinary shares of £1 each (0 shares for 2015) 1 0